The historical data show that China’s medical and pharmaceutical products exports have seen notable growth, rising from $12.32 billion in 2013 to $101.57 billion in 2023. The year-on-year growth rate peaked in 2021 at 115.52% and declined to 34.22% in 2023. The compound annual growth rate (CAGR) over the past five years stands at an impressive 42.26%. From 2019 to 2023, the sector demonstrated resilience and strong expansion, especially amid global challenges like the COVID-19 pandemic.
Looking forward, the forecasted data from 2024 to 2028 indicate continued robust growth, with exports expected to reach $227.21 billion by 2028. The forecasted five-year CAGR is 12.3%, and the total growth rate over the same period is projected at 78.62%.
Future trends to watch for:
- The impact of global health crises and their influence on demand.
- China's ongoing investments in pharmaceutical innovation and manufacturing capabilities.
- Changes in global trade policies and their effect on export dynamics.
- Adoption of digital health technologies and personalized medicine.
